Faculty Feature Mohamed Abdelbaki

Mohamed Abdelbaki, MD, was born and raised in Egypt — a country which he loves dearly and still visits every year with his family. He came to the U.S. in 2006 to start a residency in general pediatrics, followed by a fellowship in pediatric hematology, oncology and bone marrow transplant, then another fellowship in pediatric neuro-oncology.

Right after finishing both fellowships at Texas Children’s Hospital, Abdelbaki was appointed as the director of neuro-oncology at Cardinal Glennon Children’s Hospital at St. Louis University until 2015. He, then, moved to Nationwide Children’s Hospital, where he became the director of the neuro-oncology fellowship program and led the early-phase clinical trials for pediatric brain tumors.

Abdelbaki is currently the director of the Pediatric Neuro-Oncology Program at St. Louis Children’s Hospital (SLCH) and an associate professor of Pediatrics at Washington University School of Medicine in St. Louis.

He is a member of the Central Nervous System (CNS) Committee at the Children’s Oncology Group (COG) and a study committee member for the CNS non-germinomatous germ cell tumor clinical trial (ACNS2021). Additionally, he is the institutional principal investigator for the Pacific Pediatric Neuro-Oncology consortium (PNOC) — one of the largest consortia in North America conducting early phase clinical research in brain tumors — where he also serves as a member of the scientific committee and the chair of the Germ Cell Tumor Working Group.

Like many other Pediatric Neuro-Oncologists at large academic institutions, his responsibilities and interests include patient care, research and education. As for patient care, he was awarded one of the highly esteemed accolades at Nationwide Children’s Hospital for excellence in patient care in 2016 (Partners in Care, Partners in Hope Family Centered Care Award). As far as education, he was honored to receive the Distinguished Teaching Award from St. Louis University School of Medicine in 2015. On the research aspect, he currently leads the early-phase clinical trials for the Neuro-Oncology Program at SLCH. Moreover, he is the principal investigator for several clinical trials in a variety of pediatric brain tumors. Two of his clinical trials have been approved by PNOC. The first trial will test the feasibility of administering Natural Killer (NK) cells in patients with recurrent malignant brain tumors; while the second trial was also approved by Novartis Pharmaceuticals and entails testing the combination of everolimus and trametinib in children with recurrent low-grade gliomas. Lastly, he will be leading the upcoming COG trial for CNS germinomas — a rare brain tumor that affects children and young adults.

Abdelbaki has developed a global neuro-oncology program at SLCH, through which he established collaborations with several institutions around the world and has consulted upon several brain tumor patients from all over the globe. He leads an international neuro-oncology tumor board every month which is attended by neuro-oncologists from more than ten countries to discuss the care and treatment plans of brain tumor patients.

Faculty Features
Faculty Feature Bhushan Katira

Bhushan Katira, MBBS, comes to us from Toronto, along with his son Vedaant and wife Nupur. Katira is originally from India and grew up in Mumbai. Born to a teacher mother and a doctor father, Katira inherited his love for medicine and teaching. Impressed by his father’s medical practice and …

Faculty Features
Faculty Feature Stephen Sykes

Stephen Sykes, PhD, joined the Department of Pediatrics at Washington University as an associate professor in June 2021. As a scientist, he fights cancer through research. Right now, he is at war with acute myeloid leukemia (AML) which is a blood cancer that afflicts both kids and adults and has …

Faculty Features
Faculty Feature Nicole Brossier

Nicole Brossier comes from nowhere or everywhere, depending on how you look at it. She lived in three different states before her third birthday and has continued hopping around the country ever since. Fast-forwarding some years, Nicole wound up in Missouri when she started looking at college applications and chose to …